Last update:

Oncology & Cancer news

Oncology & Cancer

Researchers build first large-scale atlas of how immune cells react to mutations during cancer immunotherapy

A Cleveland Clinic-led research collaboration between Timothy Chan, MD, Ph.D., Chair of Cleveland Clinic's Global Center for Immunotherapy, and Bristol Myers Squibb has published the most comprehensive overview to date of ...

Oncology & Cancer

Hereditary colorectal cancer: Researchers reclassify a large proportion of leading gene variants as benign

The genetic confirmation of a suspected diagnosis of hereditary colorectal cancer is of great importance for the medical care of affected families. However, many of the variants identified in the known genes cannot yet be ...

Oncology & Cancer

Categorizing the epigenetic hallmarks that define cancer

Cancer mortality has just surpassed cardiovascular disease for the first time ever and one in two men, and one in three women, will be diagnosed with some form of the disease in the US, according to the NIH.

Oncology & Cancer

Report explores the role alcohol plays in new cancer cases

A little bit of alcohol was once thought to be good for you. However, as scientific research advances, we're gaining a clearer picture of alcohol's effect on health—especially regarding cancer.

Medications

New book explores the history of the phony cancer drug Krebiozen

In March 1951, Andrew Ivy—at the time, one of the most renowned scientists and medical ethicists in the U.S.—held a press conference in Chicago to announce Krebiozen, a recently discovered wonder drug that Ivy said could ...

Oncology & Cancer

New drug combination shows promise for small cell lung cancer

Researchers at the Icahn School of Medicine at Mount Sinai have made a promising breakthrough in the treatment of small cell lung cancer (SCLC). Their study, published in Science Advances and titled "ATR Inhibition Activates ...

Oncology & Cancer

Nanosurgical tool could be key to cancer breakthrough

A high-tech double-barrel nanopipette, developed by University of Leeds scientists, and applied to the global medical challenge of cancer, has—for the first time—enabled researchers to see how individual living cancer ...

Oncology & Cancer

Study: Protein helps prevent breast cancer metastasis

While better screening and improved treatments are leading to better outcomes for patients with breast cancer, 90% of breast cancer deaths are a result of metastasis, or the cancer growing and spreading to other parts of ...

Oncology & Cancer

Using AI to predict the spread of lung cancer

For decades, scientists and pathologists have tried, without much success, to come up with a way to determine which individual lung cancer patients are at greatest risk of having their illness spread, or metastasize, to other ...

Oncology & Cancer

Researchers develop test to ID aggressive ovarian cancers early

Researchers at the Johns Hopkins Kimmel Cancer Center and the Department of Gynecology and Obstetrics at the Johns Hopkins University School of Medicine have developed an algorithm to identify high-risk precancerous lesions ...

Oncology & Cancer

A method for personalizing treatment for relapsed AML

A cellular profiling method called dynamic BH3 profiling (DBP), developed by investigators at Dana-Farber Cancer Institute, has the potential to help guide personalized treatment for relapsed, drug-resistant acute myeloid ...

Oncology & Cancer

Rising alcohol-related liver cancer prompts new prediction tool

Liver cancer is the sixth most common cancer and the third most frequent cause of cancer-related death globally. However, its distribution and causes vary greatly across different regions. While areas like Eastern Asia and ...